BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 26368822)

  • 21. Novel benzenediamine derivative FC99 ameliorates zymosan-induced arthritis by inhibiting RORγt expression and Th17 cell differentiation.
    Ji J; Dou H; Li X; Song Y; Li X; Li E; Tan R; Hou Y
    Acta Biochim Biophys Sin (Shanghai); 2014 Oct; 46(10):829-36. PubMed ID: 25187413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eriodictyol suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis.
    Yang T; Li X; Yu J; Deng X; Shen PX; Jiang YB; Zhu L; Wang ZZ; Zhang Y
    Food Funct; 2020 Aug; 11(8):6875-6888. PubMed ID: 32686813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological inhibitory profile of TAK-828F, a potent and selective orally available RORγt inverse agonist.
    Shibata A; Uga K; Sato T; Sagara M; Igaki K; Nakamura Y; Ochida A; Kono M; Shirai J; Yamamoto S; Yamasaki M; Tsuchimori N
    Biochem Pharmacol; 2018 Apr; 150():35-45. PubMed ID: 29369782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis.
    Xue X; Soroosh P; De Leon-Tabaldo A; Luna-Roman R; Sablad M; Rozenkrants N; Yu J; Castro G; Banie H; Fung-Leung WP; Santamaria-Babi L; Schlueter T; Albers M; Leonard K; Budelsky AL; Fourie AM
    Sci Rep; 2016 Dec; 6():37977. PubMed ID: 27905482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells.
    Park TY; Park SD; Cho JY; Moon JS; Kim NY; Park K; Seong RH; Lee SW; Morio T; Bothwell AL; Lee SK
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18673-8. PubMed ID: 25527718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent Antagonists of RORγt, Cardenolides from Calotropis gigantea, Exhibit Discrepant Effects on the Differentiation of T Lymphocyte Subsets.
    Liu J; Bai LP; Yang F; Yao X; Lei K; Kei Lam CW; Wu Q; Zhuang Y; Xiao R; Liao K; Kuok H; Li T; Liu L
    Mol Pharm; 2019 Feb; 16(2):798-807. PubMed ID: 30592425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dehydrodiconiferyl alcohol (DHCA) modulates the differentiation of Th17 and Th1 cells and suppresses experimental autoimmune encephalomyelitis.
    Lee J; Choi J; Lee W; Ko K; Kim S
    Mol Immunol; 2015 Dec; 68(2 Pt B):434-44. PubMed ID: 26477735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoic acid receptor-related orphan receptor gamma-t (RORγt) inhibitors in clinical development for the treatment of autoimmune diseases: a patent review (2016-present).
    Sun N; Guo H; Wang Y
    Expert Opin Ther Pat; 2019 Sep; 29(9):663-674. PubMed ID: 31403347
    [No Abstract]   [Full Text] [Related]  

  • 29. Oral administration of a novel RORγt antagonist attenuates psoriasis-like skin lesion of two independent mouse models through neutralization of IL-17.
    Takaishi M; Ishizaki M; Suzuki K; Isobe T; Shimozato T; Sano S
    J Dermatol Sci; 2017 Jan; 85(1):12-19. PubMed ID: 27726924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isoflavones enhance interleukin-17 gene expression via retinoic acid receptor-related orphan receptors α and γ.
    Kojima H; Takeda Y; Muromoto R; Takahashi M; Hirao T; Takeuchi S; Jetten AM; Matsuda T
    Toxicology; 2015 Mar; 329():32-9. PubMed ID: 25583575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional Regulators of T Helper 17 Cell Differentiation in Health and Autoimmune Diseases.
    Capone A; Volpe E
    Front Immunol; 2020; 11():348. PubMed ID: 32226427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small molecule inhibitors of RORγt: targeting Th17 cells and other applications.
    Huh JR; Littman DR
    Eur J Immunol; 2012 Sep; 42(9):2232-7. PubMed ID: 22949321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small molecule allosteric inhibitors of RORγt block Th17-dependent inflammation and associated gene expression in vivo.
    Saenz SA; Local A; Carr T; Shakya A; Koul S; Hu H; Chourb L; Stedman J; Malley J; D'Agostino LA; Shanmugasundaram V; Malona J; Schwartz CE; Beebe L; Clements M; Rajaraman G; Cho J; Jiang L; Dubrovskiy A; Kreilein M; Shimanovich R; Hamann LG; Escoubet L; Ellis JM
    PLoS One; 2021; 16(11):e0248034. PubMed ID: 34752458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPARα suppresses Th17 cell differentiation through IL-6/STAT3/RORγt pathway in experimental autoimmune myocarditis.
    Chang H; Zhao F; Xie X; Liao Y; Song Y; Liu C; Wu Y; Wang Y; Liu D; Wang Y; Zou J; Qi Z
    Exp Cell Res; 2019 Feb; 375(1):22-30. PubMed ID: 30557558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small-molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms.
    Xiao S; Yosef N; Yang J; Wang Y; Zhou L; Zhu C; Wu C; Baloglu E; Schmidt D; Ramesh R; Lobera M; Sundrud MS; Tsai PY; Xiang Z; Wang J; Xu Y; Lin X; Kretschmer K; Rahl PB; Young RA; Zhong Z; Hafler DA; Regev A; Ghosh S; Marson A; Kuchroo VK
    Immunity; 2014 Apr; 40(4):477-89. PubMed ID: 24745332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of novel quinazolinedione derivatives as RORγt inverse agonist.
    Fukase Y; Sato A; Tomata Y; Ochida A; Kono M; Yonemori K; Koga K; Okui T; Yamasaki M; Fujitani Y; Nakagawa H; Koyama R; Nakayama M; Skene R; Sang BC; Hoffman I; Shirai J; Yamamoto S
    Bioorg Med Chem; 2018 Feb; 26(3):721-736. PubMed ID: 29342416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.
    Ivanov II; McKenzie BS; Zhou L; Tadokoro CE; Lepelley A; Lafaille JJ; Cua DJ; Littman DR
    Cell; 2006 Sep; 126(6):1121-33. PubMed ID: 16990136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological Evaluation of TAK-828F, a Novel Orally Available RORγt Inverse Agonist, on Murine Colitis Model.
    Igaki K; Nakamura Y; Komoike Y; Uga K; Shibata A; Ishimura Y; Yamasaki M; Tsukimi Y; Tsuchimori N
    Inflammation; 2019 Feb; 42(1):91-102. PubMed ID: 30121880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγt.
    Gege C; Albers M; Kinzel O; Kleymann G; Schlüter T; Steeneck C; Hoffmann T; Xue X; Cummings MD; Spurlino J; Milligan C; Fourie AM; Edwards JP; Leonard K; Coe K; Scott B; Pippel D; Goldberg SD
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127205. PubMed ID: 32336498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.
    Bovenschen HJ; van de Kerkhof PC; van Erp PE; Woestenenk R; Joosten I; Koenen HJ
    J Invest Dermatol; 2011 Sep; 131(9):1853-60. PubMed ID: 21654831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.